GlassScriptPhysician profile
George T Deriso
NPI 1639396518
$6,238.62
in general payments reported to CMS, 2019-2025
32 companies · $910 in 2025
The $910 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $395 · 2021: $476 · 2022: $1,384 · 2023: $882 · 2024: $816 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,163.74 | 2019-2025 | |
| Amgen INC. | $805.20 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $431.25 | 2022-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $386.77 | 2019-2025 | Brilinta |
| Merck Sharp & Dohme LLC | $308.68 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $306.73 | 2019-2024 | Xarelto |
| Pfizer INC. | $284.46 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $280.64 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $279.28 | 2022-2025 | Xience Skypoint, Cardiomems |
| Sanofi-Aventis U.S. LLC | $270.10 | 2019-2024 | |
| Boston Scientific Corporation | $254.15 | 2019-2024 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.73 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.41 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $186.79 | 2022-2025 | Nexletol |
| Novo Nordisk INC | $137.97 | 2022-2024 | Rybelsus, Ozempic |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $99.87 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.74 | 2025 | |
| Gilead Sciences, INC. | $74.91 | 2019 | |
| Amarin Pharma, INC. | $73.18 | 2019-2021 | |
| Edwards Lifesciences Corporation | $47.52 | 2019-2022 | |
| Cardiva Medical, INC. | $43.63 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.20 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $30.51 | 2019 | |
| Medicomp INC | $28.72 | 2023 | Telepatch Cardiac Monitor |
| Portola Pharmaceuticals, LLC | $26.54 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.98 | 2025 | Opsumit |
| Medtronic Vascular, INC. | $21.29 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $19.77 | 2019 | |
| Cvrx, INC. | $15.10 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $13.79 | 2023 | Assure Wcd |
| Allergan, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Deriso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.